Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Differentially expressed genes after transfection of miRNA in a human cancer cell line (miR-139-5p and miR-139-3p)

ABSTRACT: To identify differentially expressed genes by miRNAs transfection in human cancer, lung adenocarcinoma cells were subjected to agilent whole genome microarrays

ORGANISM(S): Homo sapiens

PROVIDER: GSE242241 | GEO | 2023/10/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Differentially expressed genes after transfection of miRNA in a human cancer cell line (miR-195-5p and miR-195-3p)

Project description:To identify differentially expressed genes in human cancer following miRNA transfection, lung adenocarcinoma cells were subjected to high-throughput sequencing.

2024-12-15 | GSE281258 | GEO

Differentially expressed genes after transfection of miRNA in a human cancer cell line

Project description:To identify differentially expressed genes by miRNAs transfection in human cancer, lung adenocarcinoma cells were subjected to agilent whole genome microarrays

2023-04-24 | GSE230056 | GEO

Differentially expressed genes after miRNA transfection in human cancer cell lines

Project description:To identify differentially expressed genes by miRNAs transfection in human cancer, several cell lines (lung adenocarcinoma, lung squamous cell carcinoma and small cell lung cancer) were subjected to Agilent whole genome microarrays.

2020-12-15 | GSE163187 | GEO

Differentially expressed genes after transfection of miRNA in a human cancer cell line (miR-139-5p and miR-139-3p)

Project description:Differentially expressed genes after transfection of miRNA in a human cancer cell line (miR-139-5p and miR-139-3p)

| PRJNA1012478 | ENA

Differentially expressed genes after siRNA transfection in human cancer cell line

Project description:To identify differentially expressed genes by siRNAs transfection in human colon cancer cell line, HCT116 was subjected to Agilent whole genome microarrays.

2022-07-31 | GSE208785 | GEO

Differentially expressed genes after miRNA transfection in human cancer cell lines

Project description:To identify differentially expressed genes by miRNAs transfection in human cancer, several cell lines (colon cancer and pancreatic cancer) were subjected to Agilent whole genome microarrays.

2020-08-05 | GSE155659 | GEO

Differentially expressed genes after transfection of siRNA in human cancer cell lines

Project description:To identify differentially expressed genes by siRNAs transfection in human cancer, lung squamous cell carcinoma cell lines were subjected to Agilent whole genome microarrays.

2021-09-11 | GSE183926 | GEO

Differentially expressed genes after transfection of siMAD2L1 in a human cancer cell line

Project description:To identify differentially expressed genes in human cancer following siRNA transfection, lung adenocarcinoma cells were subjected to high-throughput sequencing.

2024-12-15 | GSE281905 | GEO

Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.

Project description:Our recent study of the microRNA (miRNA) expression signature of bladder cancer (BC) by deep-sequencing revealed that two miRNA, microRNA-139-5p/microRNA-139-3p were significantly downregulated in BC tissues. The aim of this study was to investigate the functional roles of these miRNA and their modulation of cancer networks in BC cells. Functional assays of BC cells were performed using transfection of mature miRNA or small interfering RNA (siRNA). Genome-wide gene expression analysis, in silico analysis and dual-luciferase reporter assays were applied to identify miRNA targets. The associations between the expression of miRNA and its targets and overall survival were estimated by the Kaplan-Meier method. Gain-of-function studies showed that miR-139-5p and miR-139-3p significantly inhibited cell migration and invasion by BC cells. The matrix metalloprotease 11 gene (MMP11) was identified as a direct target of miR-139-5p and miR-139-3p. Kaplan-Meier survival curves showed that higher expression of MMP11 predicted shorter survival of BC patients (P = 0.029). Downregulated miR-139-5p or miR-139-3p enhanced BC cell migration and invasion in BC cells. MMP11 was directly regulated by these miRNA and might be a good prognostic marker for survival of BC patients.

| S-EPMC5021030 | biostudies-literature

miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children.

Project description:Medulloblastoma is a highly aggressive brain tumor that typically affects children, while in adults it represents ~1% of all brain tumors. Little is known about microRNA expression profile of the rare adult medulloblastoma. The main aim of this study was to identify peculiar differences in microRNA expression between childhood and adult medulloblastoma. Medulloblastomas were profiled for microRNA expression using the Exiqon Human miRNome panel (I + II) analyzing 752 microRNAs in a training set of six adult and six childhood cases. Then, the most differentially expressed microRNAs were validated in a total of 21 adult and 19 childhood cases. Eight microRNAs (miR-196b-5p, miR-183-5p, miR-200b-3p, miR-196a-5p, miR-193a-3p, miR-29c-3p, miR-33b-5p, and miR-200a-3p) were differentially expressed in medulloblastoma of adults and children. Analysis of the validation set confirmed that miR-196b-5p and miR-200b-3p were significantly overexpressed in medulloblastoma of adults as compared with those of children. We followed an in silico approach to investigate direct targets and the pathways involved for the two microRNAs (miR-196b and miR-200b) differently expressed between adult and childhood medulloblastoma. Adult and childhood medulloblastoma have different miRNA expression profiles. In particular, the differential dysregulation of miR-196b-5p and miR-200b-3p characterizes the miRNA profile of adult medulloblastoma and suggests potential targets for novel diagnostic, prognostic, or therapeutic strategies.

| S-EPMC7277606 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data